MITF (microphthalmia-associated transcription factor) plays an integral role in tumour cell differentiation, invasion and survival and has been characterised as an oncogene in 10–20% of patients with melanoma [34,71,76,77,78,79]. The gene discussed is MITF; the disease is melanoma.